Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal
- 1 April 2005
- journal article
- research article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 118 (7) , 1437-1447
- https://doi.org/10.1242/jcs.01737
Abstract
Neutrophils, which are often the first to migrate at inflamed sites, can generate leukotriene B4 from the 5-lipoxygenase pathway and prostaglandin E2 through the inducible cyclooxygenase-2 pathway. Adenosine, an endogenous autacoid with several anti-inflammatory properties, blocks the synthesis of leukotriene B4 while it potentiates the cyclooxygenase-2 pathway in fMLP-treated neutrophils, following activation of the A2A receptor. Using the murine air pouch model of inflammation, we observed that inflammatory leukocytes from mice lacking the A2A receptor have less cyclooxygenase-2 induction than wild-type animals. In human leukocytes, A2A receptor activation specifically elicited potentiation of cyclooxygenase-2 in neutrophils, but not in monocytes. Signal transduction studies indicated that the cAMP, ERK1/2, PI-3K and p38K intracellular pathways are implicated both in the direct upregulation of cyclooxygenase-2 and in its potentiation. Together, these results indicate that neutrophils are particularly important mediators of adenosine9s effects. Given the uncontrolled inflammatory phenotype observed in knockout mice and in view of the potent inhibitory actions of prostaglandin E2 on inflammatory cells, an increased cyclooxygenase-2 expression resulting from A2A receptor activation, observed particularly in neutrophils, may take part in an early modulatory mechanism promoting anti-inflammatory activities of adenosine.Keywords
This publication has 66 references indexed in Scilit:
- Attenuation of a phosphorylation-dependent activator by an HDAC–PP1 complexNature Structural & Molecular Biology, 2003
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- Leukotrienes as Mediators of AsthmaPulmonary Pharmacology & Therapeutics, 2001
- Wound Healing Is Accelerated by Agonists of Adenosine A2 (Gαs-linked) ReceptorsThe Journal of Experimental Medicine, 1997
- Effect of Cyclic AMP Level Reduction on Human Neutrophil Responses to Formylated PeptidesCellular Signalling, 1996
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- Polymorphonuclear Neutrophils: An Effective Antimicrobial ForceClinical Infectious Diseases, 1989
- Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophilsBiochemical and Biophysical Research Communications, 1983
- Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1Prostaglandins and Medicine, 1981
- Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgGClinical Immunology and Immunopathology, 1978